Young men are the group most at risk from myocarditis, especially after the second Pfizer jab

Publicly released:
International

Two studies looking at cases of myocarditis following vaccination with the Pfizer COVID-19 vaccine have confirmed that young men are at the highest risk. One study found there were around 2.13 cases of myocarditis per 100,000 people, but in young men aged 16 to 29, the risk was 10.69 cases per 100,000 people. The second study confirmed that the incidence of myocarditis, although low, increased after the receipt of the Pfizer vaccine. It found that the risk was higher after the second dose especially among young male recipients. Both studies also confirmed that most cases of myocarditis were mild or moderate in severity. 

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Massachusetts Medical Society, Web page Paper 1 - Please link to the article in online versions of your report (the URL will go live after the embargo ends).
Research Massachusetts Medical Society, Web page Paper 2 - Please link to the article in online versions of your report (the URL will go live after the embargo ends).
Journal/
conference:
New England Journal of Medicine
Research:Paper
Organisation/s: Beilinson Hospital, Israel, Hebrew University Medical Center, Israel
Funder: see individual papers for funder
Media Contact/s
Contact details are only visible to registered journalists.